[Federal Register Volume 75, Number 245 (Wednesday, December 22, 2010)]
[Notices]
[Pages 80506-80507]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-32076]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-11-10GX]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to [email protected]. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC 20503 or by fax to (202) 395-
5806. Written comments should be received within 30 days of this
notice.
Proposed Project
Persistence of Viable Influenza Virus in Aerosols--New--National
Institute for Occupational Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The National Institute for Occupational Safety and Health (NIOSH)
is authorized to conduct research to advance the health and safety of
workers under Section 20(a) (1) of the 1970 Occupational Safety and
Health Act. Influenza continues to be a major public health concern
because of the substantial health burden from seasonal influenza and
the potential for a severe pandemic. Although influenza is known to be
transmitted by infectious secretions, these secretions can be
transferred from person to person in many different ways, and the
relative importance of the different pathways is not known. The
likelihood of the transmission of influenza virus by small infectious
airborne particles produced during coughing and breathing is
particularly unclear. The question of airborne transmission is
especially important in healthcare facilities, where influenza patients
tend to congregate during influenza season, because it directly impacts
the infection control and personal protective measures that should be
taken by healthcare workers. The purpose of this study is to measure
the amount of viable influenza virus in airborne particles that are
produced by patients when they cough, and the size and quantity of the
particles carrying the virus. A better understanding of the amount of
potentially infectious material released by patients and the size of
the particles carrying the virus will assist in determining the
possible role of airborne transmission in the spread of influenza and
in devising measures to prevent it.
Volunteer participants will be recruited by a test coordinator
using a flyer describing the study. Interested potential participants
will be screened using a short health questionnaire to verify that they
have influenza-like symptoms and that they do not have any medical
conditions that would preclude their participation. Based on a previous
study using similar forms, we estimate that the health questionnaire
will require about 5 minutes to complete. Qualified participants who
agree to participate in the study will be asked to read and sign an
informed consent form. Based on the previous study, we estimate that
the informed consent form will take about 10 minutes to read and sign.
Once the informed consent form is signed, the participant will have
their oral temperature measured, two nasopharyngeal swabs will be
collected, and the participant will be asked to cough into an aerosol
particle collection system. These steps will take about 25 minutes. The
airborne particles produced by the participant during coughing will be
collected and tested.
There are no costs to the respondents other than their time. The
total estimated annual burden hours are 84.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Initial participants (phase 1) Health 44 1 5/60 4
questionnaire.
Qualified participants (phase Informed Consent 40 1 10/60 7
1). form.
No form; Time 40 1 25/60 17
required for
testing..
Initial participants (phase 2) Health 44 1 5/60 4
questionnaire.
Qualified participants (phase Informed Consent 40 1 10/60 7
2). form.
No form; Time 40 1 25/60 17
required for
testing..
Initial participants (phase 3) Health 44 1 5/60 4
questionnaire.
Qualified participants (phase Informed Consent 40 1 10/60 7
3). form.
No form; Time 40 1 25/60 17
required for
testing..
----------------------------------------------------------------------------------------------------------------
[[Page 80507]]
Dated: December 16, 2010.
Catina Conner,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2010-32076 Filed 12-21-10; 8:45 am]
BILLING CODE 4163-18-P